Oral Vaccination against Bubonic Plague Using a Live Avirulent Yersinia pseudotuberculosis Strain

T Blisnick, P Ave, M Huerre, E Carniel… - Infection and …, 2008 - Am Soc Microbiol
We evaluated the possibility of using Yersinia pseudotuberculosis as a live vaccine against
plague because it shares high genetic identity with Y. pestis while being much less virulent …

Oral vaccination against plague using Yersinia pseudotuberculosis

CE Demeure, A Derbise, E Carniel - Chemico-Biological Interactions, 2017 - Elsevier
Yersinia pestis, the agent of plague, is among the deadliest bacterial pathogens affecting
humans, and is a potential biological weapon. Because antibiotic resistant strains of …

A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and …

AK Singh, R Curtiss III, W Sun - Infection and Immunity, 2019 - Am Soc Microbiol
In this study, a novel recombinant attenuated Yersinia pseudotuberculosis PB1+ strain
(χ10069) engineered with Δ yopK Δ yopJ Δ asd triple mutations was used to deliver a Y …

An Encapsulated Yersinia pseudotuberculosis Is a Highly Efficient Vaccine against Pneumonic Plague

A Derbise, A Cerdà Marín, P Ave… - PLoS neglected …, 2012 - journals.plos.org
Background Plague is still a public health problem in the world and is re-emerging, but no
efficient vaccine is available. We previously reported that oral inoculation of a live attenuated …

Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague

W Sun, S Sanapala, H Rahav, R Curtiss 3rd - Vaccine, 2015 - Elsevier
Abstract A Yersinia pseudotuberculosis PB1+ (Yptb PB1+) mutant strain combined with
chromosome insertion of the caf1R-caf1A-caf1M-caf1 operon and deletions of yopJ and …

Protection Induced by Oral Vaccination with a Recombinant Yersinia pseudotuberculosis Delivering Yersinia pestis LcrV and F1 Antigens in Mice and Rats against …

S Majumder, RM Olson, A Singh, X Wang… - Infection and …, 2022 - Am Soc Microbiol
ABSTRACT A newly attenuated Yersinia pseudotuberculosis strain (designated Yptb1) with
triple mutation Δ asd Δ yopK Δ yopJ and chromosomal insertion of the Y. pestis caf1R-caf1M …

Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine

CE Demeure, A Derbise, C Guillas, C Gerke… - Vaccine, 2019 - Elsevier
Immunization with the live-attenuated Yersinia pseudotuberculosis VTnF1 strain producing a
Yersinia pestis F1 pseudocapsule efficiently protects mice against bubonic and pneumonic …

Progress on plague vaccine development

JA Rosenzweig, O Jejelowo, J Sha, TE Erova… - Applied microbiology …, 2011 - Springer
Yersinia pestis (YP), the gram-negative plague bacterium, has shaped human history unlike
any other pathogen known to mankind. YP (transmitted by the bite of an infected flea) …

Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine

A Derbise, C Guillas, C Gerke, E Carniel… - Vaccine, 2020 - Elsevier
A single oral inoculation to mice of the live attenuated Yersinia pseudotuberculosis VTnF1
strain producing an F1 pseudocapsule protects against bubonic and pneumonic plague …

Yersinia pestis biovar Microtus strain 201, an avirulent strain to humans, provides protection against bubonic plague in rhesus macaques

Q Zhang, Q Wang, G Tian, Z Qi, X Zhang… - Human Vaccines & …, 2014 - Taylor & Francis
Yersinia pestis biovar Microtus is considered to be a virulent to larger mammals, including
guinea pigs, rabbits and humans. It may be used as live attenuated plague vaccine …